ABCZF
Price
$22.25
Change
-$0.00 (-0.00%)
Updated
Nov 14 closing price
ANEB
Price
$1.52
Change
-$0.00 (-0.00%)
Updated
Nov 15, 02:03 PM (EDT)
84 days until earnings call
Ad is loading...

ABCZF vs ANEB

Header iconABCZF vs ANEB Comparison
Open Charts ABCZF vs ANEBBanner chart's image
Abcam
Price$22.25
Change-$0.00 (-0.00%)
Volume$4K
CapitalizationN/A
Anebulo Pharmaceuticals
Price$1.52
Change-$0.00 (-0.00%)
Volume$304
CapitalizationN/A
ABCZF vs ANEB Comparison Chart
Loading...
View a ticker or compare two or three
VS
ABCZF vs. ANEB commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCZF is a Hold and ANEB is a Hold.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (ABCZF: $22.25 vs. ANEB: $1.52)
Brand notoriety: ABCZF and ANEB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCZF: 100% vs. ANEB: 26%
Market capitalization -- ABCZF: $5.12B vs. ANEB: $39.42M
ABCZF [@Biotechnology] is valued at $5.12B. ANEB’s [@Biotechnology] market capitalization is $39.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $475.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCZF’s FA Score shows that 1 FA rating(s) are green whileANEB’s FA Score has 0 green FA rating(s).

  • ABCZF’s FA Score: 1 green, 4 red.
  • ANEB’s FA Score: 0 green, 5 red.
According to our system of comparison, ABCZF is a better buy in the long-term than ANEB.

Price Growth

ABCZF (@Biotechnology) experienced а 0.00% price change this week, while ANEB (@Biotechnology) price change was +3.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.93%. For the same industry, the average monthly price growth was -3.18%, and the average quarterly price growth was +1.55%.

Reported Earning Dates

ANEB is expected to report earnings on Feb 07, 2025.

Industries' Descriptions

@Biotechnology (-5.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
ABCZF($5.12B) has a higher market cap than ANEB($39.4M). ABCZF YTD gains are higher at: 0.000 vs. ANEB (-37.190).
ABCZFANEBABCZF / ANEB
Capitalization5.12B39.4M12,997%
EBITDAN/AN/A-
Gain YTD0.000-37.190-
P/E Ratio1770.50N/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
ABCZF: Fundamental Ratings
ABCZF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
59
SMR RATING
1..100
86
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

ABCZF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCZF has been loosely correlated with ASMB. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCZF jumps, then ASMB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCZF
1D Price
Change %
ABCZF100%
N/A
ASMB - ABCZF
64%
Loosely correlated
+2.10%
NKTX - ABCZF
53%
Loosely correlated
-7.22%
TPST - ABCZF
49%
Loosely correlated
+0.36%
TENX - ABCZF
43%
Loosely correlated
+4.00%
BCDA - ABCZF
39%
Loosely correlated
-14.26%
More

ANEB and

Correlation & Price change

A.I.dvisor tells us that ANEB and ABCZF have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANEB and ABCZF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANEB
1D Price
Change %
ANEB100%
-1.94%
ABCZF - ANEB
31%
Poorly correlated
N/A
ALDX - ANEB
28%
Poorly correlated
-3.17%
RLAY - ANEB
23%
Poorly correlated
-3.61%
IMUC - ANEB
23%
Poorly correlated
+3.28%
PMVP - ANEB
23%
Poorly correlated
-3.03%
More